TissueGen Inc:企業の製品パイプライン分析2018

【英語タイトル】TissueGen Inc - Product Pipeline Analysis, 2018 Update

GlobalDataが出版した調査資料(DATA904C12213)・商品コード:DATA904C12213
・発行会社(調査会社):GlobalData
・発行日:2018年12月
・ページ数:33
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥163,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥245,250見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
TissueGen Inc (TissueGen) is a medical device company that develops fiber for advance drug delivery, nerve regeneration and tissue engineering. The company’s products comprise pharmaceutical fibers, growth factor fibers and stent. It offers pharmaceutical fibers and growth factor fibers. TissueGen’s products are used in sciatic nerve repair, peripheral nerve regeneration, spinal cord repair, dermal wound healing and treatment of retinal disease among others. The company’s research and development department designs several fiber-based solutions which include anti-fibrillation devices, cardiovascular stents, nicotine-induced angiogenesis, ocular drug delivery and others. TissueGen is headquartered in Dallas, Texas, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company TissueGen Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
TissueGen Inc Company Overview 5
TissueGen Inc Company Snapshot 5
TissueGen Inc Pipeline Products and Ongoing Clinical Trials Overview 5
TissueGen Inc – Pipeline Analysis Overview 8
TissueGen Inc – Key Facts 8
TissueGen Inc – Major Products and Services 9
TissueGen Inc Pipeline Products by Development Stage 10
TissueGen Inc Pipeline Products Overview 12
Anti-Fibrillation Devices 12
Anti-Fibrillation Devices Product Overview 12
Archer Stent 13
Archer Stent Product Overview 13
Cardiovascular Stent 14
Cardiovascular Stent Product Overview 14
ELUTE Fiber – Diabetic Retinopathy 15
ELUTE Fiber – Diabetic Retinopathy Product Overview 15
ELUTE Fiber – Nicotine Induced Angiogenesis 16
ELUTE Fiber – Nicotine Induced Angiogenesis Product Overview 16
ELUTE Fiber – Peripheral Nerve Regeneration Scaffold 17
ELUTE Fiber – Peripheral Nerve Regeneration Scaffold Product Overview 17
ELUTE Fiber – Retinal Angiogenesis 18
ELUTE Fiber – Retinal Angiogenesis Product Overview 18
ELUTE Fiber – Smart Suture 19
ELUTE Fiber – Smart Suture Product Overview 19
ELUTE Fiber – Spinal Cord Injury Repair 20
ELUTE Fiber – Spinal Cord Injury Repair Product Overview 20
ELUTE Fiber – Urological Stent 21
ELUTE Fiber – Urological Stent Product Overview 21
TissueGen Inc – Key Competitors 22
TissueGen Inc – Key Employees 23
TissueGen Inc – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
TissueGen Inc, Recent Developments 25
Apr 16, 2018: Tissuegen Founder And Cso Dr. Kevin Nelson To Present “Enabling The Next Generation Of Drug Delivery Through Implantable Medical Devices” Session At Biomedevice Boston 25
Jan 17, 2018: TissueGen to Feature ELUTE Fiber for Advanced Drug Delivery, Nerve Regeneration and Tissue Engineering at MDM West 25
Sep 26, 2017: Edward Parent Appointed Director of Quality Assurance at TissueGen 25
Jun 05, 2017: Tissuegen to Highlight Elute Fiber for Advanced Drug Delivery, Nerve Regeneration and Tissue Engineering at MD&M East 26
Apr 19, 2017: TissueGen appoints New Faces for Growing Sales Team 26
Feb 27, 2017: TissueGen appoints new scientific advisory board member 27
Feb 27, 2017: Dr. Lisa A. Fortier Joins TissueGen’s Scientific Advisory Board 27
Nov 07, 2016: TissueGen to Showcase ELUTE Fiber for Nerve Regeneration, Tissue Engineering and Advanced Drug Delivery at Neuroscience 2016 28
Mar 28, 2016: TissueGen Announces ISO13485:2003 Certification and Record Growth Driven by ELUTE Fiber 28
Dec 15, 2015: TissueGen’s New ISO Class 7 Facility Supports FDA cGMP Drug Product Manufacturing 29
Appendix 30
Methodology 30
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
TissueGen Inc Pipeline Products and Ongoing Clinical Trials Overview 5
TissueGen Inc Pipeline Products by Equipment Type 6
TissueGen Inc Pipeline Products by Indication 7
TissueGen Inc, Key Facts 8
TissueGen Inc, Major Products and Services 9
TissueGen Inc Number of Pipeline Products by Development Stage 10
TissueGen Inc Pipeline Products Summary by Development Stage 11
Anti-Fibrillation Devices - Product Status 12
Anti-Fibrillation Devices - Product Description 12
Archer Stent - Product Status 13
Archer Stent - Product Description 13
Cardiovascular Stent - Product Status 14
Cardiovascular Stent - Product Description 14
ELUTE Fiber - Diabetic Retinopathy - Product Status 15
ELUTE Fiber - Diabetic Retinopathy - Product Description 15
ELUTE Fiber - Nicotine Induced Angiogenesis - Product Status 16
ELUTE Fiber - Nicotine Induced Angiogenesis - Product Description 16
ELUTE Fiber - Peripheral Nerve Regeneration Scaffold - Product Status 17
ELUTE Fiber - Peripheral Nerve Regeneration Scaffold - Product Description 17
ELUTE Fiber - Retinal Angiogenesis - Product Status 18
ELUTE Fiber - Retinal Angiogenesis - Product Description 18
ELUTE Fiber - Smart Suture - Product Status 19
ELUTE Fiber - Smart Suture - Product Description 19
ELUTE Fiber - Spinal Cord Injury Repair - Product Status 20
ELUTE Fiber - Spinal Cord Injury Repair - Product Description 20
ELUTE Fiber - Urological Stent - Product Status 21
ELUTE Fiber - Urological Stent - Product Description 21
TissueGen Inc, Key Employees 23
Glossary 32

List of Figures
TissueGen Inc Pipeline Products by Equipment Type 6
TissueGen Inc Pipeline Products by Development Stage 10

★調査レポート[TissueGen Inc:企業の製品パイプライン分析2018] (コード:DATA904C12213)販売に関する免責事項を必ずご確認ください。
★調査レポート[TissueGen Inc:企業の製品パイプライン分析2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆